Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Operating Income (2016 - 2025)

Sanara MedTech's Operating Income history spans 15 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Operating Income fell 53.53% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.9 million, up 236.49%, while the annual FY2025 figure was $7.3 million, 480.26% up from the prior year.
  • Operating Income reached $1.1 million in Q4 2025 per SMTI's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $6.5 million in Q4 2022 to a low of -$3.4 million in Q2 2022.
  • Average Operating Income over 5 years is -$411389.8, with a median of -$1.1 million recorded in 2021.
  • Peak YoY movement for Operating Income: tumbled 229.86% in 2022, then skyrocketed 1100.21% in 2024.
  • A 5-year view of Operating Income shows it stood at $2.3 million in 2021, then surged by 184.43% to $6.5 million in 2022, then plummeted by 103.45% to -$225995.0 in 2023, then surged by 1100.21% to $2.3 million in 2024, then tumbled by 53.53% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Operating Income are $1.1 million (Q4 2025), $2.9 million (Q3 2025), and -$31348.0 (Q2 2025).